Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression alterations with Nkapl knockout or NKAPL frameshift mutation (M349fs)

ABSTRACT: Gene expression alterations with Nkapl knockout or NKAPL frameshift mutation (M349fs)

PROVIDER: PRJNA972306 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24542400_1.fastq.gz	Fastqsanger.gz
	SRR24542400_2.fastq.gz	Fastqsanger.gz
	SRR24542401_1.fastq.gz	Fastqsanger.gz
	SRR24542401_2.fastq.gz	Fastqsanger.gz
	SRR24542402_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 52

Similar Datasets

Beagle Frameshift mutation-BE020

Project description:A frameshift mutation in the cubilin gene (CUBN) in Beagles with Imerslund–Gräsbeck syndrome (selective cobalamin malabsorption)

| PRJEB5500 | ENA

The mouse model with Foxg1 frameshift mutation uncovers the pathophysiology of FOXG1 syndrome

Project description:To investigate the gene expression patterns in Foxg1 frameshift mutation, we performed RNAseq in P1 cortices of Q84Pfs heterozygote and littermate wild type control mice.

2025-04-08 | GSE225399 | GEO

Gene expression alterations with Nkapl knockout or NKAPL frameshift mutation (M349fs)

Project description:This study aims to explore the transcriptomic changes in Nkapl-KO, Sox30-KO and Nkapl TGdel/TGdel mouse testes comparing with their wild-type testes. Fresh testes were collected from 21d wild-type, Nkapl-KO, Sox30-KO and Nkapl TGdel/TGdel mice, respectively.

2024-12-12 | GSE232415 | GEO

PD-1 Knockout Engineered T Cells for Advanced Colorectal Cancer with MSI high expression

Project description:Interventions: experimental group :PD-1 Knockout Engineered T Cells Primary outcome(s): Number of participants with Adverse Events and/or Dose Limiting Toxicities as a Measure of Safety and tolerability of dose of PD-1 Knockout T cells using Common Terminology Criteria for Adverse Events (CTCAE v4.0) in patients Study Design: historical control

| 2662961 | ecrin-mdr-crc

DNA methylation alterations and transcriptional gene silencing induced by IDH1 R132H mutation

Project description:This SuperSeries is composed of the following subset Series: GSE31126: DNA methylation alterations and transcriptional gene silencing induced by IDH1 R132H mutation [Affymetrix] GSE31133: DNA methylation alterations and transcriptional gene silencing induced by IDH1 R132H mutation [Illumina] Refer to individual Series

2012-08-12 | E-GEOD-31134 | biostudies-arrayexpress

The mouse model with Foxg1 frameshift mutation uncovers the pathophysiology of FOXG1 syndrome

Project description:The mouse model with Foxg1 frameshift mutation uncovers the pathophysiology of FOXG1 syndrome

| PRJNA935396 | ENA

programmed ribosomal frameshift

Project description:programmed ribosomal frameshift Raw sequence reads

| PRJNA310019 | ENA

A T-cell receptor targeting RUNX1 frameshift mutations in acute myeloid leukemia

Project description:Runt-related transcription factor 1 (RUNX1) is a key regulator of hematopoietic differentiation. Disruption of RUNX1 in acute myeloid leukemia (AML) induces a maturation arrest and early myeloid progenitor phenotype. RUNX1 mutations occur in 10-15% of AML and are associated with poor prognosis. One-third are frameshift mutations encoding an oncogenic protein with an elongated C-terminus translated in an alternative reading frame. Here, we investigated whether the alternative reading frame of oncogenic RUNX1 can be targeted by immunotherapy. We introduced a construct with a RUNX1 frameshift mutation into EBV-B cells with common HLA class I alleles and identified 13 neopeptides by HLA-immunopeptidomics. To investigate whether these peptides are neoantigens that can be recognized by T cells, peptide-MHC tetramers were used to screen 42 healthy individuals for specific CD8 T cells. T-cell clones were isolated for 6 neopeptides in 5 HLA alleles. Three T-cell clones recognized two HLA-B*07:02 neoantigens on AML cell line SIG-M5 C9, which was edited by CRISPR/Cas9 to express a RUNX1 frameshift mutation. The T-cell receptors (TCRs) of these clones were sequenced, and analyzed after transfer to CD8 T cells. One TCR showed effective killing of SIG-M5 C9 in vitro and in immunodeficient mice. The TCR-engineered T cells also killed patient-derived AML cells with early progenitor phenotypes, including leukemic stem cells. In conclusion, we showed that the alternative reading frame created by RUNX1 frameshift mutations can be effectively targeted, demonstrating the potential relevance of TCR-based immunotherapy to treat and improve the prognosis of patients with RUNX1-mutated AML.

2025-07-31 | PXD062938 | Pride

Transcriptomic Profiling of Murine Chondrocytes Following APOE Knockout: Insights into Gene Expression Alterations

Project description:Transcriptomic Profiling of Murine Chondrocytes Following APOE Knockout: Insights into Gene Expression Alterations

| PRJNA1258948 | ENA

CTCF knockout in zebrafish induces alterations in regulatory landscapes and developmental gene expression

Project description:CTCF knockout in zebrafish induces alterations in regulatory landscapes and developmental gene expression

| PRJNA656767 | ENA